fda glp-1 enforcement news october 2025 The New York Times spotlighted MEDVi. The had already warned the self-proclaimed 'fastest growing company in history.' FDA Issues Warnings Against Illegal

As the number of GLP-1 options grew, Novo Nordisk and Lilly invested heavily in promotional campaigns

It all comes down to the patent and proprietary information.

Current management of AKD is non-specific and includes prevention of repeated AKI, early and regular follow-up by a nephrologist, resumption and dose adjustment of statins and renin-angiotensin system inhibitors, optimization of blood pressure control, nutrition management, and nephrotoxin avoidance

Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption

In this blog, we explore how this shift provides an opportunity for CPG brands and retailers to reach consumers in more meaningful, helpful waysbuilding trust in an in